Earnings live: AstraZeneca stock rises to kick off a busy earnings week

AstraZeneca has reported Q2 2026 earnings that exceeded expectations, primarily driven by strong sales of its cancer drugs. Following the release of these financial results, AstraZeneca stock prices rose, marking the start of a busy earnings week for the market. The company's financial performance reflects the successful commercial impact of its oncology portfolio, contributing to the overall positive movement of the stock as investors react to the reported quarterly growth and revenue beats.